National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 2) (PB 19 of 2016) (Cth)

PB 19 of 2016

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 2)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated    30 March 2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 2).

(2)        This Instrument may also be cited as PB 19 of 2016.

2          Commencement

This Instrument commences on 1 April 2016.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, after entry for Allopurinol in the form Tablet 300 mg

insert:

Amitriptyline	Tablet containing amitriptyline hydrochloride 10 mg	Oral	Endep 10	50	2.33	4.15
Tablet containing amitriptyline hydrochloride 25 mg	Oral	Endep 25	50	2.51	4.33
Tablet containing amitriptyline hydrochloride 50 mg	Oral	Endep 50	50	2.88	4.70

[2] Schedule 1, entry for Captopril

substitute:

Captopril	Tablet 12.5 mg	Oral	Zedace	90	4.30	7.97
Tablet 25 mg	Oral	Capoten	90	6.22	9.83
Zedace	90	6.22	9.90
Tablet 50 mg	Oral	Capoten	90	12.27	15.07
Zedace	90	12.27	15.94

[3] Schedule 1, entry for Citalopram

omit from the column headed “Claimed Price”:          6.90        substitute:             7.40

[4] Schedule 1, entry for Codeine with Paracetamol

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Codapane Forte 20 0.74 0.92

[5] Schedule 1, entry for Eprosartan in the form Tablet 400 mg (as mesylate)

omit from the column headed “Claimed Price”:          7.38        substitute:             9.00

[6] Schedule 1, entry for Erythromycin in the form Capsule 250 mg (containing enteric coated pellets)

(a)   omit from the column headed “Determined Price”:             3.45        substitute:             4.45

(b)   omit from the column headed “Claimed Price”:  5.80        substitute:             6.80

[7] Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg

omit from the column headed “Claimed Price”:          5.44        substitute:             6.37

[8] Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg

omit from the column headed “Claimed Price”:          7.12        substitute:             8.05

[9] Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]

omit from the column headed “Claimed Price”:          5.44        substitute:             6.37

1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g

   omit from the column headed “Claimed Price”:          7.51        substitute:             8.44

2. Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 1 g

   omit from the column headed “Claimed Price”:          7.12        substitute:             8.05

3. Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

   insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Asmol 2.5 uni-dose 1 3.72 3.95

1. Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

   insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Asmol 5 uni-dose 1 3.92 4.15

1. Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)

   insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Asmol CFC-free 1 2.99 3.45